Propanc Biopharma, Inc. Common Stock (PPCB) is a publicly traded the market company. As of August 25, 2026, PPCB trades at $1.16 with a market cap of $2.46M and a P/E ratio of 0.00. PPCB moved +0.00% today. Year to date, PPCB is -91.39%; over the trailing twelve months it is -98.63%. Its 52-week range spans $0.95 to $600.00. Rallies surfaces PPCB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks PPCB insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $1.16 |
| Market Cap | $2.46M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $600.00 |
| 52-Week Low | $0.95 |
| Volume | 10.71K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
PPCB analyst coverage data. Average price target: $0.00.